Wendelin Jan Stark

This inventor holds 24 USPTO granted patents and 12 published patent applications, plus 3 CIPO patents and 29 EPO patents, primarily in Membrane Technology. Top assignees: ETH Zurich, Compagnie Generale Des Etablissements Michelin, Unversität Zürich. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wendelin Jan Stark. Retrieved from https://idiyas.com/inventor/wendelin-jan-stark

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 12)

% Patents Active = 79.2

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 29 (Patent Applications = 35)

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 172(Granted Patents)

Location History:

Winterthur, CH (2007)
Zurich, CH (2014 - 2017)
Zürich, CH (2011 - 2018)
Langenthal, CH (2017 - 2024)

Company Filing History:

Compagnie Generale Des Etablissements Michelin

Frito-Lay Trading Compnay Gmbh

Kalkfabrik Netstal Ag

patent

7. 1 out of 2,095

Michelin Recherche Et Technique S.a.

patents

8. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

Membranes

Energy Storage

Bioconjugates

Nanoparticles

Flame Spray Pyrolysis

Sensing Elements

Graphenization

Injectable Formulation

Metal Reinforcement

Molecular Code Systems

Biomolecule Detection

Metal Oxides

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12448493 - Solvent free process for manufacturing membranes (2025-10-21),

2. 12080929 - Systems and reactors for storage of electrical energy (2024-09-03),

3. 11827721 - Bioconjugates of antibodies and functionalized magnetic nanoparticles (2023-11-28),

4. 11539516 - Encoding and decoding information in synthetic DNA with cryptographic keys generated based on polymorphic features of nucleic acids (2022-12-27),

5. 11173454 - Self-supporting MOF membranes (2021-11-16),

6. 10865516 - Waterproof and breathable, porous membranes (2020-12-15),

7. 10655274 - Metallic or metallized, graphenized reinforcement (2020-05-19),

8. 10577654 - Particulate distributed sensing elements (2020-03-03),

9. 10549021 - Peristaltic pump and pumping method, in particular for use as implant (2020-02-04),

10. 10465273 - Surface graphenization of a metallic or metallized reinforcement by flame spray pyrolysis (2019-11-05),

11. 10457811 - Surface-modified calcium oxide (2019-10-29),

12. 10156028 - Spinning process (2018-12-18),

13. 9850531 - Molecular code systems (2017-12-26),

14. 9694517 - Ready-to-use metal reinforcement the surface of which is provided with metal-sulfide nanoparticles (2017-07-04),

15. 9611175 - Surface-modified calcium oxide (2017-04-04),

Title: Innovations of Wendelin Jan Stark in Energy Storage and Cancer Therapy

Introduction

Wendelin Jan Stark is a prominent inventor based in Langenthal, Switzerland, with a notable portfolio of 23 patents. His innovative contributions span various fields, primarily focusing on energy storage systems and therapeutic applications in cancer treatment. His work reflects a commitment to advancing technology in ways that enhance both energy efficiency and medical outcomes.

Latest Patents

Among his latest patents, two stand out for their significance. The first patent addresses "Systems and reactors for storage of electrical energy." This invention relates to energy storage systems and reactors that are designed to handle long-term fluctuations in renewable energy production. The unique design of these reactors features a reaction vessel with an inner volume filled with a fixed bed of particles of composition FeOx (I), making them explosion-proof and suitable for domestic use.

Another notable invention is the "Bioconjugates of antibodies and functionalized magnetic nanoparticles." This patent focuses on innovative bioconjugates that utilize antibodies in conjunction with functionalized magnetic nanoparticles. These bioconjugates hold potential for significant advancements in cancer therapy by effectively targeting and removing circulating tumor cells from patients.

Career Highlights

Wendelin has had a remarkable career, particularly during his tenure at prestigious institutions such as ETH Zurich and Eidgenössische Technische Hochschule Zurich. His involvement in research within these reputable institutions has undoubtedly contributed to his innovative output and the development of his notable patents.

Collaborations

Throughout his career, Wendelin Jan Stark has collaborated with other esteemed researchers, including Robert Nikolaus Grass and Milan Fedurco. These collaborations have likely enriched his research endeavors by combining diverse expertise and perspectives.

Conclusion

Wendelin Jan Stark's dedication to innovation in the fields of energy storage and medical applications positions him as a leader among contemporary inventors. His groundbreaking patents not only contribute to intellectual advancements but also have the potential to make a significant impact on both environmental sustainability and healthcare solutions. As a result, his work serves as an inspiration for future innovations in technology and medicine.

Profile summary based on public USPTO records.